Human skin begins tanning in seconds, and here's how

November 3, 2011 in Cancer

We all know that human skin tans after days spent in the sun. That relatively slow process has known links to ultraviolet (and specifically UVB) exposure, which leads to tanning only after it damages the DNA of skin cells. Now, researchers reporting online on November 3 in Current Biology, a Cell Press publication, have uncovered a much speedier path to pigmentation.

The newly discovered response is likely to provide rapid protection against , the researchers say, and understanding how it works might impact the design of sunscreens in the future.

"Our work shows that a dedicated UV receptor allows to immediately detect and respond to UV light," said Elena Oancea of Brown University. "We found that human skin detects light using a mechanism similar to that used by the retina, on a timescale significantly faster than was previously known."

That immediate response occurs within a matter of seconds in response to UVA light. UVA accounts for about 95 percent of the ultraviolet radiation at the Earth's surface. UVB makes up the other 5 percent. Scientists did know that UVA causes oxidative damage to cells and leads to pigment darkening in a matter of minutes. The question was how.

Oancea's team found that exposure of pigment-producing cells from human skin to UVA leads to the early synthesis of in a process involving . What's more, the skin's UVA response depends on rhodopsin, a light-sensitive ingredient also found in the retina of the eye.

"Our findings show that both the eye and skin—the only two organs constantly exposed to solar radiation—use similar molecular mechanisms to decode light," Oancea said.

The studies show that melanin production can be measured in human skin cells within an hour of UV exposure. That's key because melanin doesn't just make the skin darker. It also protects the skin by absorbing and converting it to a less harmful energy in the form of heat.

"We hypothesize that the early melanin production triggered by rhodopsin activation provides a first line of defense against ultraviolet light-induced damage," Oancea says. "If this is the case, then this pathway and its protective capacity should be taken into consideration in the design and use of broad-spectrum sunscreens."

Provided by Cell Press search and more info website

5 /5 (1 vote)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

rwinners
Nov 04, 2011

Rank: not rated yet
But, hey! The article didn't give that secret away!
Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 10 hours ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 13 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 15 hours ago | popularity not rated yet | comments 0


Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...